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Lysine-porphyrin conjugate 4i has potent photosensitive antibacterial effect on clinical
isolated bacterial strains such as Methicillin-resistant Staphylococcus aureus (MRSA),
Escherichia coli, and Pseudomonas aeruginosa. The mechanism of photodynamic
antibacterial chemotherapy of 4i (4i-PACT) in vitro and the treatment effect in vivo was
investigated in this paper. Atomic force microscopy (AFM) revealed that 4i-PACT can
effectively destroy membrane and wall of bacteria, resulting in leakage of its content. This
was confirmed by dual fluorescent staining with acridine orange/ethidium bromide and
measuring materials absorption at 260 nm. Agarose gel electrophoresis measurement
showed that 4i-PACT can damage genomic DNA. Healing of wound in rat infected by
mixed bacteria showed that the efficiency of 4i-PACT is dependent on the dose of light.
These results showed that 4i-PACT has promising bactericidal effect both in vitro and
in vivo.
Keywords: lysine-porphyrin conjugate, photodynamic antimicrobial chemotherapy, antibiotic resistance,
photosensitizer, mixed bacterial-infected wounds
INTRODUCTION
The antibiotics for treating common infections have become less effective in recent years. Nearly
1000 of resistance-related β-lactamases, which inactivate the antibiotics, have been identified, a 10
times increase since 1990 (Davies and Davies, 2010; Laxminarayan et al., 2013). This situation made
us at the dawn of post antibiotic era (Ryono, 2014). So, it is urgent to find alternative approaches
against antibiotics-resistant bacteria. Generally, there are two solutions to this problem. One is to
develop novel antibacterial agents, the other is to develop novel physical sterilization. The latter
includes radiation sterilization (Nusbaum and Rose, 1979), high pressure electric field sterilization
(Sasagawa et al., 2006), microwave sterilization (Dovigo et al., 2009), magnetic sterilization (Haile
et al., 2008), and pulse light sterilization (Krishnamurthy et al., 2004). Chemical agents and physical
approaches are combined in Photodynamic antimicrobial chemotherapy (PACT) (Wainwright,
1998), which consists of a non-toxic photosensitizer (PS), illumination light of an appropriate
wavelength, and ambient molecular oxygen. However, not all of the PS can be used in PACT
treatment of bactrerial infection. Only special designed PS can match the PACT demand (Meng
et al., 2015). So from this point of view, PACT falls between novel antibacterial agents and novel
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physical sterilization approaches, namely, a physicochemical
treatment. With the advantage of circumventing the bacterial
multidrug resistance in the treatment of infection, PACT has
received great attention in recent years.
The PS is the crutial element in PACT. In the past
few decades, several types of PSs have been reported, such
as porphyrin, heme, phthalocyanine, phenothiazinium dyes,
BODIPY, methylene blue, conjugated polyelectrolytes, cationic
functionalized fullerene, as well as nanoparticals (Wainwright
and Crossley, 2004; Wainwright, 2010; Fu et al., 2013; Sperandio
et al., 2013). As an ideal PS candidate for photodynamic therapies
(Stojiljkovic et al., 2001), Porphyrin can efficiently kill Gram-
positive bacteria. Meanwhile, in combination with agents that
permeabilize the highly organized outer membrane of Gram-
negative bacteria, only cationic PSs, or noncationic PSs are able to
kill Gram-negative species (Mbakidi et al., 2013; Prasanth et al.,
2014).
In a previous paper, we have reported the synthesis,
characterization, and in vitro photodynamic antimicrobial
activity of basic amino acid-porphyrin conjugates (Meng et al.,
2015), a new class of PSs. Among them, compared with other
PSs, 4i exhibits a broader spectrum of photoinactivation in vitro,
improved biocompatibility and stability (Bertolini et al., 1990;
Nitzan et al., 1992; Tomé et al., 2004; Liu et al., 2012; Gomes
et al., 2013; Mbakidi et al., 2013; Prasanth et al., 2014). This paper
reported the mechanism of bacterial inactivation by 4i-PACT
and its effectiveness in vivo on experimental mixed bacterial
infected rat wounds. The results showed that 4i-PACT had potent
bactericidal effect both in vitro and in vivo.
MATERIALS AND METHODS
Bacterial Culture
In this experiment, three clinical bacterial strains, MRSA,
Escherichia Coli, and Pseudomonas aeruginosa were isolated at
the Tianjin Armed Police Hospital. These bacterial strains were
cultured in Luria Bertani (LB) medium. A single colony was used
to inoculate 10 mL of liquid medium. The bacteria was grown
under aerobic condition at 37◦C in a shaking incubator (200 rpm)
for 18 h. The bacteria was then collected by centrifugation and
resuspended in an equal volume of PBS (Zhao et al., 2014).
Chemicals and Instruments
Porphyrin derivative 4i was synthesized and characterized with
the procedure reported by Meng et al. (2015). For clarity,
synthetic procedure and characterization detail are omitted.
The chemical structure of porphyrin derivative 4i is shown in
Figure 1.
Light from a semiconductor laser (7404, Intense, USA) with a
wavelength of 650 nm was delivered on the sample via an optic
fiber. The energy density of light spot was measured by a light
power meter (LM1; Carl Zeiss).
MIC and MBC Determinations
Three bacterial strains were treated with the same procedure.
As an example of all of the strains, the treatment of MRSA
FIGURE 1 | Structure of 5,10,15,20-trakis(4-((S)-2,6-
diaminohexanamido)-phenyl) porphyrin (4i).
FIGURE 2 | Survival fraction of three bacterial strains treated by
different concentration of 4i with and without illumination. Light toxicity
marked by MRSA + L, Escherichia coli + L, Pseudomonas aeruginosa + L
and dark toxicity marked by MRSA – L, E. coli − L, P. aeruginosa − L
respectively.
is described in detail. Experiments were performed in 96-
well flat bottom plates. Twenty microliter of MRSA suspension
and 180 µL of the compounds were added to each well. The
final concentration of the bacterial in the mixture was 106
colony-forming units/mL (CFU/mL). 4i with different mole
concentrations were prepared, e.g., 0.98, 1.95, 3.91, 7.8, 15.6,
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31.25, 62.5, 125, 250, and 500 µM, respectively. Plates were
kept in the dark for 30 min at 37◦C and then exposed to light
illumination for 30 min or kept in the dark to provide dark
control samples. After light exposure, the samples were incubated
in dark at 37◦C and CFU was evaluated after 18 h. Three sets
of independent experiments were performed (Rodrigues et al.,
2013).
Dose-Dependent Photoinactivation
Effects
Suspensions of bacteria (107 CFU/mL) were incubated at 37◦C
for 30 min in the dark with 4i (3.91, 7.81, 15.63, 31.25, and
62.50 µM). The suspensions were then loaded into a 96-well
plate and illuminated with light with energy density of 6 J/cm2
for the photoreaction. After illumination, 100 µL mixture from
each well was taken to determine the CFU. The mixtures were
serially diluted to 101, 102, 103, 104, and 105 times of the initial
concentrations using PBS. 100 µL of each dilution was plated
onto LB agar plates and incubated for 18 h at 37◦C in dark.
The CFUs were counted, and each experiment was performed
in triplicate. The surviving fractions of bacteria were expressed
as ratios of CFU produced by bacteria treated with PSs and light
(Grinholc et al., 2008).
Atomic Force Microscopy (AFM) Imaging
The bacteria were examined with atomic force microscope
(Veeco Multi Mode 8/B0021, Veeco German) equipped with
Antimony doped silicon of conical shape (Veeco). The force
constant is 3 N/m. Bacterial samples in a concentration of 107
CFU/mL were dropped on to the mica plate surface (about
0.5 cm2), naturally dried at ambient temperature, then were
scanned in intelligent mode (Wu et al., 2014).
Fluorescence Imaging
In order to study 4i-PACT effect on the permeability of the
bacterial membrane, the samples after 4i-PACT treatment were
stained with 4 µL of the acridine orange/ethidium bromide
(AO/EB) double fluorescent dyes mixture (100 mg/L of AO and
100 mg/L of EB) for 5 min in dark. Then 5 µL of the stained
mixture was dropped on a microscopic glass slide with cover glass
and immediately checked by the fluorescent microscope (Nikon
Eclipse Ti/B0004, Nikon, Japan) at 200×magnification (Sui et al.,
2013).
Genomic DNA Extraction and
Electrophoresis
Bacterial suspensions (1 × 107 CFU/mL) were treated with
10 µM 4i as mentioned in experiment 2.4 above. After
exposing to the laser light, the genomic DNA was extracted
from bacteria immediately using a Genomic DNA Purification
Kit (Solarbio, Beijing). DNA samples were gently mixed with
6x loading buffer (Solarbio, Beijing). DNA was analyzed by
electrophoresis with 0.8% agarose gel in 1x TAE buffer at 70 V
for 30 min. DNA green was incorporated into the agarose
gel. The 15000 bp DNA Marker (TAKARA) was used as a
molecular weight marker with DNA fragments between 250
FIGURE 3 | Fluorescence microscopy image of three bacterial strains
treated by 10 µM 4i with and without illumination. (a) MRSA treated by
4i-PACT, (d) 4i with no light, (g) control; (b) P. aeruginosa treated by 4i-PACT,
(e) 4i with no light, (h) control; (c) E. coli treated by the 4i-PACT, (f) 4i with no
light, (i) control.
FIGURE 4 | AFM image of three bacterial strains treated by 10 µM 4i
with and without illumination. (a) MRSA treated by 4i-PACT, (d) 4i with no
light, (g) control; (b) P. aeruginosa treated by 4i-PACT, (e) 4i with no light, (h)
control; (c) E. coli treated by 4i-PACT, (f) 4i with no light, (i) control.
and 15000 bp. The light dose had been optimized in vitro
in our experiments. Light dose higher than 6 J/cm2 did not
improve the efficacy, while the light with lower dose results
in a lower bactericidal ability. Without PS 4i, light exposure
alone on bacteria in vitro did not have significant bactericidal
effect.
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FIGURE 5 | Agarose gel electrophoresis of three bacterial strains after treated by 10 µM 4i with and without illumination. Bacteria treated with 4i-PACT
(4i + L), treated with 4i in the dark (4i–L) and no treatment (control).
Exudation Study for Measuring Materials
Absorption at 260 nm
DNA and RNA have absorbance at 260 nm, so exudation study
was conducted by measuring the materials absorption at 260 nm
for bacteria treated by 10 µM 4i-PACT, 10 µM 4i alone, and PBS,
respectively. After treatment, 400 µL of the bacterial suspensions
(1 × 108) were filtered to remove the bacteria. OD at 260 nm
(OD260) of the supernatant was recorded for treated and pre-
treatment control groups.
Excisional Wound Model and
Establishment of Infection
The wound healing characteristic of the 4i-PACT was evaluated
using a rat model (Dash et al., 2001). The Animal Care
and Use Committee of PUMC approved all experimental
protocols involving rats. Sprague–Dawley rats from Beijing HFK
Bioscience CO.,LTD, weighing about 220 g, were housed at one
rat one cage and maintained in dark except PACT treatment.
The rats were first anesthetized via intraperitoneal injection of
chloral hydrate (300 mg/kg). Then their back was shaved with
an electric razor, followed by a depilatory agent. Four circular
wounds (1.5 cm in diameter ) with a depth of the skin layers
were prepared along both sides of the spine. Immediately after
that, suspension (50 µL) of mixed bacteria (109 CFU/mL MRSA,
5× 108 CFU/mL E. coli, 5× 108 CFU/mL P. aeruginosa) in sterile
PBS was inoculated onto the surface of each wound with a pipet
tip and then smeared onto the wound surface with an inoculating
loop. Next, a bandage was wrapped around each rat to protect
the shaved skin and the wounds from other harm. This state was
kept for 1 day. Then these rats were used as the wounds model for
mixed bacterial infection.
4i-PACT In Vivo
Thirty rats with wound infected by mixed bacteria were divided
into five groups: (A) no treatment control; (B) 4i + 100 J/cm2
Light; (C) 4i + 50 J/cm2 Light; (D) 4i + 25 J/cm2 Light; (E) 4i
+ 12.5 J/cm2 Light. Since light illumination doses alone in this
study do not have significant effect on the wound healing, we did
not provide light illumination doses alone groups.
Twenty four hours after infection, 50 µL of 4i solution (40 µM
in PBS) was injected under eschar of the wound of groups B–
E. Then after 30 min for the PS uptaken by the bacteria, rats in
groups B–E were illuminated with 650 nm laser (100 mW/cm2),
the light dose was kept at 100, 50, 25, 12.5 J/cm2 for group B–E,
respectively. On the next day, the same light dose was given to
increase the antibacterial effect of 4i-PACT. The above treatment
was repeated three times.
The day, on which rats were infected, was regarded as day
1, the widths and lengths of the wounds were measured using a
vernier caliper on days 1, 2, 3, 4, 5, 6, 7, 8, 10, and 12. The viability
of each group of rats after infection was recorded, respectively.
Meanwhile bacterial CFUs in the wound were calculated in
the following ways. Swabs collected from the rat wounds were
cultured in PBS. Viable bacteria in the PBS were counted by
making 10-fold serial dilutions and culturing the dilutions on LB
agar for 18 h at 37◦C. Then CFUs were counted manually (Kumar
et al., 2011; Sudheesh Kumar et al., 2012).
Statistical Analysis
All data are presented as mean ± SEM. The significance of
differences between sample means was determined by Student’s
t-test using SPSS 19.0.
RESULTS AND DISCUSSION
MIC and MBC Determinations
The minimum inhibitory and bactericidal concentration (MIC
and MBC) of 4i toward bacteria was studied. Bacterial
suspensions (106 CFU/mL) were incubated with the 4i in dark
for 30 min at 37◦C and then exposed to light illumination
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FIGURE 6 | Wound healing ratio over time in bacterial infected rats
with and without 4i-PACT. Each point represents the mean ratio of the area
of the original wound. Data is expressed as mean ± SEM. N = 6 in each
group.
(650 nm, 6 J/cm2). The concentration of 4i required to make
the suspensions (106 CFU/mL) change visibly from turbid to
clear was regarded as the minimum inhibitory concentration
(MIC), while the concentration at which no more than five
colonies were observed on the plates was regarded as the
minimum bactericidal concentration (MBC). As shown in Table
1, compound 4i had high bacterial photoinactivation ability with
MIC values of 3.91 µM against MRSA, 1.95 µM against E. coli,
and 7.81 µM against P. aeruginosa, respectively; MBC values of
7.81 µM against MRSA, 3.91 µM against E. coli, and 15.60 µM
against P. aeruginosa. Meanwhile the dark toxicity of the 4i is
relatively weak, with MIC > 62.5 µM, MBC > 125 µM for
TABLE 1 | Minimal inhibitory concentration (MIC, µM) and minimal
bactericidal concentration (MBC, µM) of 4i against MRSA, Pseudomonas
aeruginosa, Escherichia coli.
Clinical bacterial strain Light toxicity Dark toxicity
MIC MBC MIC MBC
MRSA 3.91 7.81 62.50 125.00
P. aeruginosa 7.81 15.60 250 > 500
E. coli 1.95 3.91 62.50 125.00
TABLE 2 | Bacterial content exudation in the control (PBS), 4i alone, and
4i-PACT treatment groups (n = 4, mean ± SD) measured at 260 nm.
Clinical bacterial strain Increase in OD260 relative to pre-treatment (%)
Control 4i alone 4i-PACT
MRSA 2.86 ± 0.34 10.98 ± 0.41 247.87 ± 17.87
P. aeruginosa 2.04 ± 0.29 9.54 ± 0.28 188.98 ± 19.32
E. coli 2.98 ± 0.33 13.31 ± 0.38 336.67 ± 28.08
these three strains. From the values of MBC, it can be concluded
that 4i-PACT is very effective toward E coli, P. aeruginosa is
the most resistant strain and MRSA is at the middle of them.
So 4i-PACT seemly shows higher bactericidal activity toward
Gram-negative strains than that of Gram-positive strains. This
trend is different from the PACT of other positive charged PS
(Sahu et al., 2009; Kharkwal et al., 2011; Ke et al., 2014), which
show higher photoinactivation toward the Gram-positive strains
than the Gram-negative counterparts. The latter possess a highly
organized outer membrane which imparts a higher permeability
barrier for the PSs to penetrate into the bacteria. In this study, 4i-
PACT shows higher bactericidal effect toward E. coli than MRSA
and P. aeruginosa. This unexpected result can be interpreted
based upon the chemical structure of 4i, pi–pi interaction of
large planar porphyrin rings, hydrogen bonding interaction and
charge interaction from four lysine moieties. The ensemble
interaction and difference of the outside membrane structure
of these strains lead to the unexpected bactericidal effect of
4i-PACT.
Dose-Dependent Photoinactivation
Effects
The photoinactivation effect of 4i against MRSA, E. coli and
P. aeruginosa strains was dose-dependent (Figure 2). A sharp
decrease in bacterial survival fraction with increase of the
concentration was observed. These three strains were incubated
with 3.9 µM 4i in the dark for 30 min at 37◦C, then illuminated
by the 650 nm laser with power of 6 J/cm2. 4.35, 6.96, and 3.56
log10 reduction in bacterial survival fraction was observed for the
clinical isolated MRSA, E. coli and P. aeruginosa, respectively. As
a control, 4i did not show any bactericidal effect to these strains
in dark at less than 10 µM.
Morphology Changes
Changes of the bacterial structure can be clearly revealed at
morphological level by AFM. The representative results are
shown in Figure 3. The normal ball shape structure of MRSA
(Figure 3g), the rod-like shape of P. aeruginosa (Figure 3h)
and E. coli (Figure 3i) was observed without any treatment.
The size and shape of the bacteria agree with that reported
in previous study (Eaton et al., 2008). For these three strains
treated by 4i in the dark (Figures 3d-f), it can be seen that the
bacterial structure is complete. Particles scattered at the surface
of bacteria may be the aggregates of 4i. In the groups treated by
4i-PACT (Figures 3a–c), it was found that bacteria is damaged
and fragmented. Some irregular aggregation of the dead corpse
was detected. Researchers have found that the roughness, size and
shape of bacterial strains are slightly altered after PACT treatment
with Toluidine Blue O (Sahu et al., 2009; Jin et al., 2010; Lin et al.,
2012). The leakage from Staphylococcus aureus cell suspension is
greatly increased (Sahu et al., 2009), suggesting that cytoplasmic
materials are lost through the damaged bacterial membrane.
Results in this study showed that bacterial strains are completely
broken into pieces. Thus, 4i-PACT treatment appeared to have
potent effect on the bacterial envelope, including damaging the
bacterial wall and membrane.
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FIGURE 7 | The mean bacterial counts of the swabs collected from the
rat wounds during the 8 days post infection. Data is expressed as
mean ± SEM. N = 6 in each group.
Membrane Integrity
The fluorescence microscopy was used to investigate the
permeability of bacterial membrane before and after 4i-PACT.
Fluorescent dyes (AO/EB), as the indicator of cell membrane
damage, were used to assess the antibacterial activity of 4i-
PACT. Living bacteria was observed as green and dead as red,
respectively. Figures 4g–i show fluorescence microscopy images
of the control samples, where no 4i was added, the bacteria
is dispersed and alive with green color. Figures 4a–c are the
fluorescence microscopy images of MRSA, P. aeruginosa and
E. coli treated by 4i-PACT (10 µM, 6J/cm2, 650 nm), respectively,
where most of the bacteria is dead with red color. On the other
hand, fluorescence microscopy images of MRSA (Figure 4d),
P. aeruginosa (Figure 4e), and E. coli (Figure 4f) treated by10 µM
4i without illumination showed little bactericidal effect. The
above results mean that 4i-PACT can damage the membrane of
bacteria and change the permeability of the bacterial membrane.
This again explains why the antimicrobial effect of 4i-PACT is so
strong.
Photodynamic Effect on Genomic DNA
The influence of 4i-PACT on bacteria was further studied from
a genomic point of view such as DNA leakage or damage. The
electrophoresis graph (Figure 5) shows that the DNA bands,
extracted from the processed bacterial cells, disappear after
4i-PACT (10 µM, 6 J/cm2, 650 nm), while a clear DNA band is
detected in the control groups with no 4i-PACT or treated by
4i alone. This result is consistent with the AFM morphological
study as well as the fluorescent staining, which reveal that the
4i-PACT breaks the bacterial membrane and wall and causes the
leakage of genomic DNA. The absence of DNA bands can be
attributed to either the leakage of bacteria membrane or the break
of the DNA. So we conducted another independent experiment.
The naked DNA extracted from each strains was treated by
4i-PACT. The agarose gel electrophoresis graph still shows no
FIGURE 8 | The viability of rats against days post infection for treated
versus not treated.
DNA bands. This result indicated that 4i-PACT can break DNA
into pieces. This phenomenon is consistent with the previous
results (Menezes et al., 1990; Choi et al., 2010; Lin et al., 2012).
Generally, the reason for multidrug resistance in cellular level is
due to the drug only blocked or weakened the partial binding site
or signal pathway, while the whole cellular bodies were kept, so
it is easy to develop multidrug resistance. Double effects of 4i-
PACT, destroying bacterial membrane and damaging the DNA,
can account for the vanish of DNA band in electrophoresis graph.
This is the reason why bacterial strains have no resistant to
4i-PACT.
Bacterial Content Exudation
Release of intracellular components is a good indicator of
membrane integrity. Small ions such as potassium and phosphate
tend to exude first, followed by large molecules such as DNA,
RNA, and other materials. Since these nucleotides have strong
UV absorption at 260 nm, measuring the absorbance at 260 nm
can reveal the information of membrane integrity (Denyer and
Hugo, 1991; Chen and Cooper, 2002). As shown in Table 2,
after 10 µM 4i-PACT, the bacterial content exudation from
MRSA, P. aeruginosa, and E. Coli are increased by 247.87, 188.98,
336.67%, respectively, compared with pre-treatment samples,
while changes less than 10% was observed in the control or 4i
group. This result is consistent with that of AFM and fluorescent
images. These data are larger than that reported by Sahu et al.
(2009), which were only 20–60% increase compared with the
control groups.
In Vivo Antibacterial Activity and
Wound-Healing Effect
In vivo antibiotics experiment, generally 5 or 10 times MIC
was chosen as the working concentration. 40 µM of 4i, five
times of MIC (Singh et al., 2006; Dai et al., 2009) was chosen
as the working dose. The antibacterial effect of 4i-PACT with
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different light dose was studied. The wound healing rate is highly
light dose dependent (Figure 6). Control group A, with no
treatment, showed less wound healing at each observation time
point. A rapid wound healing was observed in the treatment of
groups C (50 J/cm2) and D (25 J/cm2) during the day 4 to 8
after infection (p < 0.05). After day 8, wound healing became
slow till completely healed on day 12. However, in the groups B
(100 J/cm2) and E (12.5 J/cm2), rapid wound closure happened
from day 7 to 10. On the day 8, mean wound area ratios of B–E
were 0.4252 ± 0.0512, 0.1515 ± 0.0312, 0.1823 ± 0.0777, and
0.2273 ± 0.0239, respectively, but in the control group wound
area ratio was 0.6619± 0.0834, indicating B–E groups had better
wound healing ratio compared with the control group. Almost
total wound closure was observed by the day 12 post infection in
all treated groups.
The viable bacteria in wound tissue were counted as an index
of the bactericidal effect of 4i-PACT. On days 1, 2, 3, 4, 5,
6, 7, 8 post infection, PACT-treated groups exhibited obvious
reduction in bacterial viability compared with the no treatment
control group (Figure 7). At the same time point, the decrease of
viable bacterial count is in the order of light illumination dose,
B > C > D > E. This suggests that 4i-PACT accelerates wound
healing via bactericidal effect against MRSA, P. aeruginosa, and
E. coli. However, the wound healing ratio is in the order of
C > D > E > B, instead of paralleling of the bactericidal effect.
This indicates that 4i-PACT effect on normal tissue should be
considered. A rationalized interpretation can be given based
upon the multiple function of 4i-PACT in vivo: 4i-PACT not
only photoinactivates bacteria, but also causes the normal tissue
damaged and repaired. The observed effect is the balance of
the ensemble results. For either a weaker 4i-PACT with a lower
illumination dose (12.5 J/cm2 in group E), or a stronger 4i-PACT
with a higher illumination dose (100 J/cm2 in group B), the
total results are not good. The best result is from treatment with
medium light dose like group C (50 J/cm2). So for the practical
application of PACT further study is requires.
In the no treatment control group, two rats died on day 2 and
day 4, rats in other groups all survived the experiment. Therefore,
the viability of rats post treatment indicates that 4i-PACT is more
efficient in the treatment of mixed bacterial infection (Figure 8).
CONCLUSION
This paper studied the photoinactivation mechanism of 4i-
PACT in vitro and its wound healing effect on wound rat
model infected by mixed bacteria. 4i-PACT (3.91 µM, 6J/cm2,
650 nm) had a broad potent antibacterial spectrum: 4.35,
6.96, and 3.56 log10 reduction in bacterial survival for MRSA,
E. coli, and P. aeruginosa, respectively. AFM revealed that 4i-
PACT can destroy bacterial wall and membrane. This is further
confirmed by Dual fluorescent staining with AO/EB. Agarose gel
electrophoresis indicated that 4i-PACT can damage the genomic
DNA of bacteria. Absorbance at 260 nm reveals that 4i-PACT
could cause bacterial content leakage. 4i-PACT breaks not only
bacterial wall but also the genomic DNA. That is why the bacterial
strains have no resistance to 4i-PACT. Wound healing effect on
mixed bacterial infected rat model revealed that 4i-PACT in vivo
is highly potent and light-dose dependent. The ensemble effect is
the balanced effect of 4i-PACT both to normal tissue and bacterial
strains. The best light dose is 50 J/cm2. Overall, 4i-PACT is a
highly efficient treatment modality for bacterial infection in vitro
or in vivo.
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